Is it important to model the impact of blood flow on the dose of drugs delivered transcutaneously?

Journal of Vascular Research

Volumn 46, Issue 4, 2009, Pages 267-269

  Clough, Geraldine ^a   Gush, Rodney ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Moor Instruments Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; VASOACTIVE AGENT; XENOBIOTIC AGENT; VASODILATOR AGENT;

BLOOD FLOW; BLOOD VESSEL DIAMETER; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; DRUG DELIVERY SYSTEM; DRUG MONITORING; EDITORIAL; ELECTROOSMOSIS; ELECTROPORATION; HUMAN; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MICRODIALYSIS; MICROVASCULATURE; MODEL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; BIOLOGICAL MODEL; BLOOD FLOW VELOCITY; DIFFUSION; DOSE RESPONSE; DRUG EFFECT; ECHOGRAPHY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; MICROCIRCULATION; NOTE; SKIN; SKIN ABSORPTION; TIME; VASCULARIZATION; VASODILATATION;

ADMINISTRATION, CUTANEOUS; BLOOD FLOW VELOCITY; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MICROCIRCULATION; MODELS, CARDIOVASCULAR; REGIONAL BLOOD FLOW; SKIN; SKIN ABSORPTION; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 67649970831     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000176041     Document Type: Editorial

References (19)

1. Deanfield JE, Halcox JP, Rabelink TJ: Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285-1295.
2. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR: Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006; 27: 503-508.
3. Nugroho AK, Della Pasqua O, Danhof M, Bouwstra JA: Compartmental modeling of transdermal iontophoretic transport. II. In vivo model derivation and application. Pharm Res 2005; 22: 335-346.
4. de Mul FF, Blaauw J, Aarnoudse JG, Smit AJ, Rakhorst G: Diffusion model for iontophoresis measured by laser-Doppler perfusion flowmetry, applied to normal and preeclamptic pregnancies. J Biomed Opt 2007; 12: 014032.
5. Tesselaar E, Henricson J, Jonsson S, Sjöberg F: A time-response model for analysing of drug transport and blood flow response during iontophoresis of acetylcholine and sodium nitroprusside. J Vasc Res 2009;46:270-277.
6. Henricson J, Tesselaar E, Persson K, Nilsson G, Sjoberg F: Assessment of microvascular function by study of the dose-response effects of iontophoretically applied drugs (acetylcholine and sodium nitroprusside) - methods and comparison with in vitro studies. Microvasc Res 2007; 73: 143-149.
7. Bungay PM, Morrison PF, Dedrick RL: Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci 1990; 46: 105-119.
8. Singh P, Roberts MS: Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J Pharmaceutical Sci 1994; 83: 783-791.
9. Sun H, Bungay PM, Elmquist WF: Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain. J Pharmacol Exp Ther 2001; 297: 991-1000.
10. Clough GF, Boutsiouki P, Church MK, Michel CC: Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 2002; 302: 681-686.
11. Boutsiouki P, Thompson JP, Clough GF: Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch Toxicol 2001; 75: 321-328.
12. Stagni G, O'Donnell D, Liu YJ, Kellogg DL, Morgan T, Shepherd AM: Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis. J Control Release 2000; 63: 331-339.
13. Stagni G, O'Donnell D, Liu YJ, Kellogg DL Jr, Shepherd AM: Iontophoretic current and intradermal microdialysis recovery in humans. J Pharmacol Toxicol Methods 1999; 41: 49-54.
14. Grossmann M, Jamieson MJ, Kellogg DL Jr, Kosiba WA, Pergola PE, Crandall CG, et al: The effect of iontophoresis on the cutaneous vasculature: evidence for current-induced hyperemia. Microvasc Res 1995; 50: 444-452.
15. Ramsay JE, Ferrell WR, Greer IA, Sattar N: Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. J Cardiovasc Pharmacol 2002; 39: 9-17.
16. Horiuchi Y, Droog EJ, Henricson J, Wikström T, Lennquist S, Sjöberg F: Role of histamine release in nonspecific vasodilatation during anodal and cathodal iontophoresis. Microvasc Res 2004; 67: 192-196.
17. Ferrell WR, Ramsay JE, Brooks N, Lockhart JC, Dickson S, McNeece GM, et al: Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. J Vasc Res 2002; 39: 447-455.
18. Droog EJ, Henricson J, Nilsson GE, Sjoberg F: A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects. Microvasc Res 2004; 67: 197-202.
19. Brown MB, Traynor MJ, Martin GP, Akomeah FK: Transdermal drug delivery systems: skin perturbation devices. Methods Mol Biol 2008; 437: 119-139.